Previous reports point to the enhanced hepatic expression of ADAM10 [35] and ADAM17 [36] in mouse models of MASLD, most likely reflecting their involvement in MASLD progression. The gene discussed is ADAM10; the disease is metabolic dysfunction-associated steatotic liver disease.